Role of Tris-CaEDTA as an adjuvant with nebulised tobramycin in cystic fibrosis patients with Pseudomonas aeruginosa lung infections: A randomised controlled trial.
primary studies published RCT
Details- 2020
- Puvvadi R
The effectiveness of a mobile high-frequency chest wall oscillation (HFCWO) device for airway clearance.
primary studies published RCT
Details- 2020
- Leemans G
Long-term azithromycin use is not associated with QT prolongation in children with cystic fibrosis.
primary studies published RCT
Details- 2020
- Magaret AS
Oral Glutathione and Growth in Cystic Fibrosis: A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Trial.
primary studies published RCT
Details- 2020
- Bozic M
Does synbiotic supplementation affect the quality of life in children with cystic fibrosis? A pilot randomized controlled clinical trial.
primary studies published RCT
Details- 2020
- Bilan N
Ivacaftor in People With Cystic Fibrosis and a 3849+10kb C âT or D1152H Residual Function Mutation.
primary studies published RCT
Details- 2020
- Kerem E
Effects of music therapy as an adjunct to chest physiotherapy in children with cystic fibrosis: A randomized controlled trial.
primary studies published RCT
Details- 2020
- Montero-Ruiz A
Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study.
primary studies published RCT
Details- 2020
- Tiddens HAWM
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
primary studies published RCT
Details- 2020
- Hewer SCL
Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial.
primary studies published RCT
Details- 2020
- López-Neyra A